CD36 deficiency leads to choroidal involution via COX2 down-regulation in rodents.

BACKGROUND: In the Western world, a major cause of blindness is age-related macular degeneration (AMD). Recent research in angiogenesis has furthered the understanding of choroidal neovascularization, which occurs in the "wet" form of AMD. In contrast, very little is known about the mechanisms of the predominant, "dry" form of AMD, which is characterized by retinal atrophy and choroidal involution. The aim of this study is to elucidate the possible implication of the scavenger receptor CD36 in retinal degeneration and choroidal involution, the cardinal features of the dry form of AMD. METHODS AND FINDINGS: We here show that deficiency of CD36, which participates in outer segment (OS) phagocytosis by the retinal pigment epithelium (RPE) in vitro, leads to significant progressive age-related photoreceptor degeneration evaluated histologically at different ages in two rodent models of CD36 invalidation in vivo (Spontaneous hypertensive rats (SHR) and CD36-/- mice). Furthermore, these animals developed significant age related choroidal involution reflected in a 100%-300% increase in the avascular area of the choriocapillaries measured on vascular corrosion casts of aged animals. We also show that proangiogenic COX2 expression in RPE is stimulated by CD36 activating antibody and that CD36-deficient RPE cells from SHR rats fail to induce COX2 and subsequent vascular endothelial growth factor (VEGF) expression upon OS or antibody stimulation in vitro. CD36-/- mice express reduced levels of COX2 and VEGF in vivo, and COX2-/- mice develop progressive choroidal degeneration similar to what is seen in CD36 deficiency. CONCLUSIONS: CD36 deficiency leads to choroidal involution via COX2 down-regulation in the RPE. These results show a novel molecular mechanism of choroidal degeneration, a key feature of dry AMD. These findings unveil a pathogenic process, to our knowledge previously undescribed, with important implications for the development of new therapies.

Évaluation des Conférences ministérielles euro-méditerranéennes de Valence, Crète, Naples et Dublin

La Conférence inaugurale de Barcelone a marqué, en novembre 1995, le début d'un long processus de rapprochement et de solidarité entre 27 partenaires (35 pays depuis le 1er mai 2004 et 37 à moyen terme). Cette initiative est censée revêtir un caractère permanent et évolutif sous l'angle institutionnel. De par sa dimension stratégique, le Processus de Barcelone, ci-après Processus, constitue l'instrument le plus important et le plus concret pour le dialogue et la coopération entre l'Union européenne (UE), ses Etats membres et les partenaires méditerranéens2. Pour être efficace, et pas uniquement rhétorique ou virtuel, le Partenariat euro-méditerranéen, ci-après Partenariat, doit se bâtir sur des valeurs universelles, capables de garantir un minimum de cohérence et de crédibilité à un projet extrêmement complexe, fragile et, par sa propre nature, constamment menacé de paralysie. En effet, il n'est pas toujours aisé de faire prévaloir des actions à caractère centripète aux tentations et tendances centrifuges qui caractérisent la région. Les changements et les événements exceptionnels survenus récemment, tant dans le domaine international qu'au sein de l'Union, ont rendu nécessaires l'approfondissement et le renforcement institutionnel des relations euro-méditerranéennes. Le Processus est appelé à se consolider d'urgence, pour être compris et accepté par une opinion publique de plus en plus sceptique et déconcertée par l'actualité internationale. La récente création de l'Assemblée parlementaire euro-méditerranéenne (APEM) - qui sera dotée de trois commissions permanentes3 - et la constitution prochaine à Alexandrie de la Fondation Euromed pour le dialogue entre les cultures et les civilisations, représentent des réponses logiques et encourageantes à cet état d'esprit plus ou moins généralisé

Biological treatments in Behçet's disease: beyond anti-TNF therapy.

Behçet's disease (BD) is universally recognized as a multisystemic inflammatory disease of unknown etiology with chronic course and unpredictable exacerbations: its clinical spectrum varies from pure vasculitic manifestations with thrombotic complications to protean inflammatory involvement of multiple organs and tissues. Treatment has been revolutionized by the progressed knowledge in the pathogenetic mechanisms of BD, involving dysfunction and oversecretion of multiple proinflammatory molecules, chiefly tumor necrosis factor- (TNF-) α, interleukin- (IL-) 1β, and IL-6. However, although biological treatment with anti-TNF-α agents has been largely demonstrated to be effective in BD, not all patients are definite responders, and this beneficial response might drop off over time. Therefore, additional therapies for a subset of refractory patients with BD are inevitably needed. Different agents targeting various cytokines and their receptors or cell surface molecules have been studied: the IL-1 receptor has been targeted by anakinra, the IL-1 by canakinumab and gevokizumab, the IL-6 receptor by tocilizumab, the IL12/23 receptor by ustekinumab, and the B-lymphocyte antigen CD-20 by rituximab. The aim of this review is to summarize all current experiences and the most recent evidence regarding these novel approaches with biological drugs other than TNF-α blockers in BD, providing a valuable addition to the actually available therapeutic armamentarium.

Lettre de Gaspare Spontini à Hector Berlioz, [Paris], mercredi 17 avril [1839] (manuscrit autographe)

Lettre autographe signée sur papier bleuté. - Date restituée d'après le contexte : Spontini sollicite de Berlioz un article de soutien dans le "Journal des débats", à propos de son projet de réforme de la musique sacrée, ce que fit Berlioz dans le n° du 10 mai 1839

Immune cell impact of three differently coated lipid nanocapsules: pluronic, chitosan and polyethylene glycol.

Lipid nanocapsules (NCs) represent promising tools in clinical practice for diagnosis and therapy applications. However, the NC appropriate functionalization is essential to guarantee high biocompatibility and molecule loading ability. In any medical application, the immune system-impact of differently functionalized NCs still remains to be fully understood. A comprehensive study on the action exerted on human peripheral blood mononuclear cells (PBMCs) and major immune subpopulations by three different NC coatings: pluronic, chitosan and polyethylene glycol-polylactic acid (PEG) is reported. After a deep particle characterization, the uptake was assessed by flow-cytometry and confocal microscopy, focusing then on apoptosis, necrosis and proliferation impact in T cells and monocytes. Cell functionality by cell diameter variations, different activation marker analysis and cytokine assays were performed. We demonstrated that the NCs impact on the immune cell response is strongly correlated to their coating. Pluronic-NCs were able to induce immunomodulation of innate immunity inducing monocyte activations. Immunomodulation was observed in monocytes and T lymphocytes treated with Chitosan-NCs. Conversely, PEG-NCs were completely inert. These findings are of particular value towards a pre-selection of specific NC coatings depending on biomedical purposes for pre-clinical investigations; i.e. the immune-specific action of particular NC coating can be excellent for immunotherapy applications.

9/1/20, quai d'Orsay, dernier Conseil suprême avant la ratification du traité de paix, sortie de M. Nitti [et de M.] Scialoga [i. e. Scialoja] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 57555

Criptosistema ElGammal mediante curvas hiperelípticas

En este trabajo se ha realizado un estudio de las curvas hiperelípticas, y más concretamente, de su variedad jacobiana. Se han implementado una serie de operaciones matemáticas sobre elementos de la variedad jacobiana (Divisores), como la suma, el doblado o el cálculo del divisor mitad, así como el cálculo del cardinal de la jacobiana. Una vez realizada esta parte se ja implementado, haciendo uso de estas operaciones, una variante del criptosistema ElGammal mediante curvas hiperelípticas, así como la firma diital del mismo.

Atac al problema del logaritme discret mitjançant l'algorisme de Pohlig-Hellman

En els darrers anys, l'ús de les corbes el·líptiques en criptografia basada en el problema del logaritme discret s'ha anat incrementant, degut al fet que garanteixen la mateixa seguretat emprant claus més petites. Tot i això, per tal que una corba el·líptica sigui criptogràficament útil, cal que el seu cardinal satisfaci certes propietats, altrament existeixen atacs que resolen el problema del logaritme discret. En aquest treball de final de carrera s'ha implementat l'atac de Pohlig-Hellman en el grup multiplicatiu d'un cos finit i sobre el grup de punts d'una corba el·líptica.

Determinació del subgrup de 7-Sylow d'una corba el·líptica

La criptografia de corbes el·líptiques ha despertat un interés molt gran degut a que garanteix la mateixa seguretat amb longituds de claus molt més petites.Tot i això, queden problemes oberts com el de trobar el cardinal d'una corba el·líptica sobre un cos finit, que és un problema computacionalment difícil. En aquest treball estudiem i implementem un algoritme per determinar el subgrup de 7-Sylow d'una corba el·líptica. El coneixement d'aquest subgrup ens dóna informació parcial del cardinal de la corba, concretament, la potència del factor 7 que té el cardinal. Així, si aquesta potència fos molt gran, la corba s'hauria de descartar per a usos criptogràfics basats en el problema del logaritme discret.

Lord Curzon, M. Lloyd George, M. Nitti [à Londres, début janvier 1920] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 57547

Trisecció de divisors sobre corbes hiperel·líptiques de gènere 2

La criptografia amb corbes el·liptiques i hiperel·líptiques ha adquirit un gran interès en els últims anys. Per a determinar si una corba és bona criptogràficament és necessari, en el cas d'una corba el·liptica trobar el cardinal del grup de punts i, en el cas d'una corba hiperel·líptica trobar el cardinal de la varietat jacobiana. En aquest treball donem mètodes per trobar els trisecats d'un divisor d'una corba de gènere 2. Això ens permetrà determinar el subgrup de 3-Sylow i trobar la major potencia de 3 que divideix al cardinal de la seva Jacobiana, obtenin així informació sobre aquest cardinal.

Transitions familiales et brouilles conjugales : cumulation ou compensation des problèmes d'intimité à travers les phases du parcours de vie familial ?

Cette étude esquisse, sur la base d'un grand échantillon représentatif et longitudinal de couples vivant en Suisse et du point de vue des femmes ayant répondu à l'enquête, un tableau de l'évolution des problèmes conjugaux rencontrés au cours des différentes phases de la vie familiale. Le processus de dégradation de la relation est reconstitué à partir de 2 mesures faites dans un intervalle de 5 ans. La genèse des difficultés conjugales est considérée à travers le prisme des transitions familiales, en particulier la naissance des enfants, leur entrée à l'école et leur départ du domicile parental. L'analyse révèle le potentiel déstabilisateur de ces transitions pour le couple. Les bouleversements de l'équilibre relationnel évoluent, dans certains cas, vers un cumul de difficultés qui envahissent l'espace conjugal pour déboucher sur une situation rapidement inextricable.

Embryonic vascular endothelial cells are malleable to reprogramming via Prox1 to a lymphatic gene signature.

BACKGROUND: In vivo studies demonstrate that the Prox1 transcription factor plays a critical role in the development of the early lymphatic system. Upon Prox1 expression, early lymphatic endothelial cells differentiate from the cardinal vein and begin to express lymphatic markers such as VEGFR-3, LYVE-1 and Podoplanin. Subsequent in vitro studies have found that differentiated vascular endothelial cells can be reprogrammed by Prox1 to express a lymphatic gene profile, suggesting that Prox1 can initiate the expression of a unique gene signature during lymphangiogenesis. While the in vitro data suggest that gene reprogramming occurs upon Prox1 expression, it is not clear if this is a direct result of Prox1 in vascular endothelial cells in vivo. RESULTS: Overexpression of Prox1 in vascular endothelial cells during embryonic development results in the reprogramming of genes to that of a more lymphatic signature. Consequent to this overexpression, embryos suffer from gross edema that results in embryonic lethality at E13.5. Furthermore, hemorrhaging and anemia is apparent along with clear defects in lymph sac development. Alterations in junctional proteins resulting in an increase in vascular permeability upon Prox1 overexpression may contribute to the complications found during embryonic development. CONCLUSION: We present a novel mouse model that addresses the importance of Prox1 in early embryonic lymphangiogenesis. It is clear that there needs to be a measured pattern of expression of Prox1 during embryonic development. Furthermore, Prox1 reprograms vascular endothelial cells in vivo by creating a molecular signature to that of a lymphatic endothelial cell.

Knowledge management for systems biology a general and visually driven framework applied to translational medicine

Background: To enhance our understanding of complex biological systems like diseases we need to put all of the available data into context and use this to detect relations, pattern and rules which allow predictive hypotheses to be defined. Life science has become a data rich science with information about the behaviour of millions of entities like genes, chemical compounds, diseases, cell types and organs, which are organised in many different databases and/or spread throughout the literature. Existing knowledge such as genotype - phenotype relations or signal transduction pathways must be semantically integrated and dynamically organised into structured networks that are connected with clinical and experimental data. Different approaches to this challenge exist but so far none has proven entirely satisfactory. Results: To address this challenge we previously developed a generic knowledge management framework, BioXM™, which allows the dynamic, graphic generation of domain specific knowledge representation models based on specific objects and their relations supporting annotations and ontologies. Here we demonstrate the utility of BioXM for knowledge management in systems biology as part of the EU FP6 BioBridge project on translational approaches to chronic diseases. From clinical and experimental data, text-mining results and public databases we generate a chronic obstructive pulmonary disease (COPD) knowledge base and demonstrate its use by mining specific molecular networks together with integrated clinical and experimental data. Conclusions: We generate the first semantically integrated COPD specific public knowledge base and find that for the integration of clinical and experimental data with pre-existing knowledge the configuration based set-up enabled by BioXM reduced implementation time and effort for the knowledge base compared to similar systems implemented as classical software development projects. The knowledgebase enables the retrieval of sub-networks including protein-protein interaction, pathway, gene - disease and gene - compound data which are used for subsequent data analysis, modelling and simulation. Pre-structured queries and reports enhance usability; establishing their use in everyday clinical settings requires further simplification with a browser based interface which is currently under development.